Eloxx Pharmaceuticals, Inc. (ELOX)
14.60
-0.28
(-1.88%)
USD |
OTCM |
Oct 08, 11:23
Eloxx Pharmaceuticals EPS Diluted (Quarterly) : -0.6631 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6631 |
| March 31, 2026 | -0.8566 |
| June 30, 2025 | -5.450 |
| September 30, 2023 | -1.307 |
| June 30, 2023 | -1.962 |
| March 31, 2023 | -2.876 |
| December 31, 2022 | -2.917 |
| September 30, 2022 | -3.466 |
| June 30, 2022 | -4.901 |
| March 31, 2022 | -5.364 |
| December 31, 2021 | -5.598 |
| September 30, 2021 | -4.586 |
| June 30, 2021 | -21.73 |
| March 31, 2021 | -8.655 |
| December 31, 2020 | -6.104 |
| September 30, 2020 | -6.594 |
| June 30, 2020 | -7.862 |
| March 31, 2020 | -13.92 |
| December 31, 2019 | -11.64 |
| September 30, 2019 | -12.89 |
| June 30, 2019 | -15.93 |
| March 31, 2019 | -13.27 |
| December 31, 2018 | -15.65 |
| September 30, 2018 | -12.75 |
| June 30, 2018 | -16.80 |
| Date | Value |
|---|---|
| March 31, 2018 | -12.48 |
| June 30, 2017 | -64.94 |
| March 31, 2017 | -72.00 |
| December 31, 2016 | -32.00 |
| September 30, 2016 | -40.00 |
| June 30, 2016 | -45.27 |
| March 31, 2016 | -120.00 |
| December 31, 2015 | -152.00 |
| September 30, 2015 | -16.00 |
| June 30, 2015 | -72.70 |
| March 31, 2015 | -72.00 |
| December 31, 2014 | -624.00 |
| September 30, 2014 | -304.00 |
| June 30, 2014 | -311.07 |
| March 31, 2014 | -696.00 |
| December 31, 2013 | -384.00 |
| September 30, 2013 | -624.00 |
| June 30, 2013 | -1168.00 |
| March 31, 2013 | -800.00 |
| December 31, 2012 | -800.00 |
| September 30, 2012 | -2400.00 |
| June 30, 2012 | -1501.60 |
| March 31, 2012 | -1600.00 |
| December 31, 2011 | -1600.00 |
| September 30, 2011 | -1965.60 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.1781 |
| CorMedix, Inc. | 0.281 |
| BioStem Technologies, Inc. | -0.5178 |
| Wave Life Sciences, Inc. | -0.34 |
| Axsome Therapeutics, Inc. | -0.9906 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.502M |
| Total Expenses (Quarterly) | 4.502M |
| Enterprise Value | -1.904M |
| Earnings Yield | -56.69% |
| Normalized Earnings Yield | -57.15 |